Latest Articlesddd
Presenting Fate Therapeutics Today we are presenting Fate Therapeutics (FATE); a clinical-stage company developing programmed cellular immunotherapies …
Presenting UroGen Pharma UroGen Pharma (URGN) focuses on cancers and urologic diseases. It announced its fourth quarter …
Vertex and Regeneron Will Survive the Coronavirus Market Vertex We picked Vertex (VRTX) on March 18, …
COVID-19 and the Nation's Hospitals Disagreeable news with regard to the nation's hospitals is their unpreparedness …
Exelixis, Takeda and Japanese RCC Patients Today we learned from Exelixis (EXEL) that Takeda Pharmaceutical Company …
The Week in Review #49 The Stars from the Weeks Preceding the Novel Coronavirus Outbreak Forty …
Coronavirus: The Possible Treatments While Moderna’s (MRNA) vaccine is being tested and its stock price continued …
A Market in Chaos The Market is in chaos. When this happens the market needs to …
COVID-19, The Market Rebounding and the Biotech Firms That Did and Didn't Rally The Market Rebounding …
Stock Market Fluctuations and Volatility Only history can remind us that what’s going on recently with …
Compugen Soaring in an Extremely Down Market The stocks' prices tumbled today except for very few …
NanoViricides and COVID-19 NanoViricides (NNVC), a development-stage nano-biopharmaceutical company with a proprietary and patented drug development …
Treating and Preventing COVID-19 Treating COVID-19, Gilead Sciences With regard to treating patients with COVID-19 we …
The Market Soared Being optimistic about the greatness of American scientific capability does not mean underestimating …
Gilead Sciences to Acquire Forty Seven Gilead Sciences (GILD) and Forty Seven (FTSV) announced today that the companies …
Moderna Therapeutics Among all the firms announcing their interest in working towards designing and producing a …
COVID-19 and the Stock Market The coronavirus that causes COVID-19 is the topic that swallowed all other …
Regeneron, Moderna, and COVID-19 The spread of COVID-19, minute creatures that seem to be trying to …
Gilead and Moderna Stocks Will Outperform Today As stated in Prohost Letter #439 Gilead (GILD) investigational …
Prohost Letter #439 The Coronavirus Outbreak - COVID-19 The news announced that the coronavirus (now known …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
